INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAC2. A total of 7 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,831,173 | – | 4,500,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 98,354,000 | $105,134,820 | 2.32% |
| CSS LLC/IL | 4,500,000 | $4,831,173 | 0.32% |
| WOLVERINE ASSET MANAGEMENT LLC | 7,792,000 | $8,378,083 | 0.09% |
| CITIGROUP INC | 262,000 | $280,497 | 0.00% |
| JPMORGAN CHASE & CO | 175,000 | $187,688 | 0.00% |
| JANE STREET GROUP, LLC | 60,000 | $64,219 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |